Enhanced angiotensin II-induced cardiac and aortic remodeling in ACE2 knockout mice

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 18, Issue 2, 2013, Pages 138-151

  Alghamri, Mahmoud S ^a   Weir, Nathan M ^a   Anstadt, Mark P ^a   Elased, Khalid M ^a   Gurley, Susan B ^b   Morris, Mariana ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

aorta; cardiac dysfunction; echocardiography; oxidative stress; remodeling; renin angiotensin system

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; COLLAGEN; INTERLEUKIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA DISEASE; AORTA REMODELING; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART DISEASE; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART PROTECTION; HEART REMODELING; HEART WEIGHT; HISTOPATHOLOGY; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONTENT; VASCULITIS; WILD TYPE;

ANGIOTENSIN II; ANIMALS; AORTA; BLOOD PRESSURE; HEART RATE; INFUSION PUMPS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDYL-DIPEPTIDASE A; VENTRICULAR REMODELING;

EID: 84873642707     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248412460124     Document Type: Article

References (67)

1. Donoghue M, Hsieh F, Baronas E, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res. 2000 ; 87 (5). E1 - E9
2. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A. human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem. 2000 ; 275 (43). 33238-33243
3. Vickers C, Hales P, Kaushik V, et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem. 2002 ; 277 (17). 14838-14843
4. Grobe JL, Mecca AP, Lingis M, et al. Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7). Am J Physiol Heart Circ Physiol. 2007 ; 292 (2). H736 - H742
5. McCollum LT, Gallagher PE, Ann TE. Angiotensin-(1-7) attenuates angiotensin II-induced cardiac remodeling associated with upregulation of dual-specificity phosphatase 1. Am J Physiol Heart Circ Physiol. 2012 ; 302 (3). H801 - H810
6. Crackower MA, Sarao R, Oudit GY, et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002 ; 417 (6891). 822-828
7. Yamamoto K, Ohishi M, Katsuya T, et al. Deletion of angiotensin- converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II. Hypertension. 2006 ; 47 (4). 718-726
8. Gurley SB, Allred A, Le TH, et al. Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice. J Clin Invest. 2006 ; 116 (8). 2218-2225
9. Dong B, Yu QT, Dai HY, et al. Angiotensin-converting enzyme-2 overexpression improves left ventricular remodeling and function in a rat model of diabetic cardiomyopathy. J Am Coll Cardiol. 2012 ; 59 (8). 739-747
10. Sriramula S, Cardinale JP, Lazartigues E, Francis J. ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension. Cardiovasc Res. 2011 ; 92 (3). 401-408
11. Nakamura K, Koibuchi N, Nishimatsu H, et al. Candesartan ameliorates cardiac dysfunction observed in angiotensin-converting enzyme 2-deficient mice. Hypertens Res. 2008 ; 31 (10). 1953-1961
12. Gurley SB, Coffman TM. Angiotensin-converting enzyme 2 gene targeting studies in mice: mixed messages. Exp Physiol. 2008 ; 93 (5). 538-542
13. Ferreira AJ, Santos RA, Bradford CN, et al. Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases. Hypertension. 2010 ; 55 (2). 207-213
14. Zisman LS, Keller RS, Weaver B, et al. Increased angiotensin-(1-7)- forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2. Circulation. 2003 ; 108 (14). 1707-1712
15. Kassiri Z, Zhong J, Guo D, et al. Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction. Circ Heart Fail. 2009 ; 2 (5). 446-455
16. Ohtsuki M, Morimoto S, Izawa H, et al. Angiotensin converting enzyme 2 gene expression increased compensatory for left ventricular remodeling in patients with end-stage heart failure. Int J Cardiol. 2010 ; 145 (2). 333-334
17. Burrell LM, Johnston CI, Tikellis C, Cooper ME. ACE2, a new regulator of the renin-angiotensin system. Trends Endocrinol Metab. 2004 ; 15 (4). 166-169
18. Huentelman MJ, Grobe JL, Vazquez J, et al. Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats. Exp Physiol. 2005 ; 90 (5). 783-790
19. Zhong J, Basu R, Guo D, et al. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction. Circulation. 2010 ; 122 (7). 717-728
20. Kirchhoff F, Krebs C, Abdulhag UN, et al. Rapid development of severe end-organ damage in C57BL/6 mice by combining DOCA salt and angiotensin II. Kidney Int. 2008 ; 73 (5). 643-650
21. Xu S, Zhi H, Hou X, Cohen RA, Jiang B. IkappaBbeta attenuates angiotensin II-induced cardiovascular inflammation and fibrosis in mice. Hypertension. 2011 ; 58 (2). 310-316
22. Mazzolai L, Nussberger J, Aubert JF, et al. Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system. Hypertension. 1998 ; 31 (6). 1324-1330
23. Domenighetti AA, Wang Q, Egger M, Richards SM, Pedrazzini T, Delbridge LM. Angiotensin II-mediated phenotypic cardiomyocyte remodeling leads to age-dependent cardiac dysfunction and failure. Hypertension. 2005 ; 46 (2). 426-432
24. Wang HX, Zhang QF, Zeng XJ, Wang W, Tang CS, Zhang LK. Effects of angiotensin III on protein, DNA, and collagen synthesis of neonatal cardiomyocytes and cardiac fibroblasts in vitro. J Cardiovasc Pharmacol Ther. 2010 ; 15 (4). 393-402
25. Houser SR, Margulies KB, Murphy AM, et al. Animal models of heart failure: a scientific statement from the American Heart Association. Circ Res. 2012 ; 111 (1). 131-150
26. Xu J, Carretero OA, Liao TD, et al. Local angiotensin II aggravates cardiac remodeling in hypertension. Am J Physiol Heart Circ Physiol. 2010 ; 299 (5). H1328 - H1338
27. Essick EE, Ouchi N, Wilson RM, et al. Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling. Am J Physiol Heart Circ Physiol. 2011 ; 301 (3). H984 - H993
28. Galderisi M, de DO. Risk factor-induced cardiovascular remodeling and the effects of angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol. 2008 ; 51 (6). 523-531
29. Tsutsui H, Matsushima S, Kinugawa S, et al. Angiotensin II type 1 receptor blocker attenuates myocardial remodeling and preserves diastolic function in diabetic heart. Hypertens Res. 2007 ; 30 (5). 439-449
30. Ebrahimian T, Li MW, Lemarie CA, et al. Mitogen-activated protein kinase-activated protein kinase 2 in angiotensin II-induced inflammation and hypertension: regulation of oxidative stress. Hypertension. 2011 ; 57 (2). 245-254
31. Marvar PJ, Thabet SR, Guzik TJ, et al. Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension. Circ Res. 2010 ; 107 (2). 263-270
32. Dai Q, Xu M, Yao M, Sun B. Angiotensin AT1 receptor antagonists exert anti-inflammatory effects in spontaneously hypertensive rats. Br J Pharmacol. 2007 ; 152 (7). 1042-1048
33. Jin HY, Song B, Oudit GY, et al. ACE2 deficiency enhances angiotensin II-mediated aortic profilin-1 expression, inflammation and peroxynitrite production. PLoS One. 2012 ; 7 (6). e38502
34. Grobe N, Cool D.R, Grunwald WC, Elased K, Morris M.. Molecular imaging using mass spectrometry to localize renal angiotensin converting enzyme 2 (ACE2) activity [abstract]Grobe N, Cool D.R, Grunwald WC, Jr., Elased K, Morris M. FASEB J. 2011 ;:
35. Shewale SV, Anstadt MP, Horenziak M, et al. Sarin causes autonomic imbalance and cardiomyopathy: an important issue for military and civilian health. J Cardiovasc Pharmacol. 2012 ; 60 (1). 76-87
36. Respress JL, Wehrens XH.. Transthoracic echocardiography in mice. J Vis Exp. 2010 ;:
37. Peshavariya HM, Dusting GJ, Selemidis S. Analysis of dihydroethidium fluorescence for the detection of intracellular and extracellular superoxide produced by NADPH oxidase. Free Radic Res. 2007 ; 41 (6). 699-712
38. Benov L, Sztejnberg L, Fridovich I. Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical. Free Radic Biol Med. 1998 ; 25 (7). 826-831
39. Moser B, Ebert L. Lymphocyte traffic control by chemokines: follicular B helper T cells. Immunol Lett. 2003 ; 85 (2). 105-112
40. Moos MP, John N, Grabner R, et al. The lamina adventitia is the major site of immune cell accumulation in standard chow-fed apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2005 ; 25 (11). 2386-2391
41. Maurer M, von SE. Macrophage inflammatory protein-1. Int J Biochem Cell Biol. 2004 ; 36 (10). 1882-1886
42. Elased KM, Cunha TS, Coffman TM, Gurley SB, Morris M. A novel assay for measurement of angiotensin converting enzyme 2 (ACE2) activity. Circulation. 2005 ; 112: U204
43. Chappell MC, Allred AJ, Ferrario CM. Pathways of angiotensin-(1-7) metabolism in the kidney. Nephrol Dial Transplant. 2001 ; 16 (Suppl 1). 22-26
44. Harmer D, Gilbert M, Borman R, Clark KL. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett. 2002 ; 532 (1-2). 107-110
45. Oudit GY, Kassiri Z, Patel MP, et al. Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice. Cardiovasc Res. 2007 ; 75 (1). 29-39
46. Elased KM, Cunha TS, Gurley SB, Coffman TM, Morris M. New mass spectrometric assay for angiotensin-converting enzyme 2 activity. Hypertension. 2006 ; 47 (5). 1010-1017
47. Diez-Freire C, Vazquez J, Correa de Adjounian MF, et al. ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR. Physiol Genomics. 2006 ; 27 (3). 12-19
48. Mercure C, Yogi A, Callera GE, et al. Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart. Circ Res. 2008 ; 103 (11). 1319-1326
49. Grobe N, Elased KM, Cool DR, Morris M. Mass spectrometry for the molecular imaging of angiotensin metabolism in kidney. Am J Physiol Endocrinol Metab. 2012 ; 302 (8). E1016 - E1024
50. Karamyan VT, Speth RC. Enzymatic pathways of the brain renin-angiotensin system: unsolved problems and continuing challenges. Regul Pept. 2007 ; 143 (1-3). 15-27
51. Nako H, Kataoka K, Koibuchi N, et al. Novel mechanism of angiotensin II-induced cardiac injury in hypertensive rats: the critical role of ASK1 and VEGF. Hypertens Res. 2012 ; 35 (2). 194-200
52. Touyz RM. Reactive oxygen species and angiotensin II signaling in vascular cells - implications in cardiovascular disease. Braz J Med Biol Res. 2004 ; 37 (8). 1263-1273
53. Byrne JA, Grieve DJ, Bendall JK, et al. Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ Res. 2003 ; 93 (3). 802-805
54. Takimoto E, Kass DA. Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension. 2007 ; 49 (2). 241-248
55. Hori M, Nishida K. Oxidative stress and left ventricular remodelling after myocardial infarction. Cardiovasc Res. 2009 ; 81 (3). 457-464
56. Xia H, Suda S, Bindom S, et al. ACE2-mediated reduction of oxidative stress in the central nervous system is associated with improvement of autonomic function. PLoS One. 2011 ; 6 (7). e22682
57. Letavernier E, Perez J, Bellocq A, et al. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension. Circ Res. 2008 ; 102 (6). 720-728
58. Burlew BS, Weber KT. Cardiac fibrosis as a cause of diastolic dysfunction. Herz. 2002 ; 27 (2). 92-98
59. Egger M, Domenighetti AA. Adaptive and maladaptive remodeling of cardiomyocyte excitation-contraction coupling by angiotensin II. Trends Cardiovasc Med. 2010 ; 20 (3). 78-85
60. Moreo A, Ambrosio G, De CB, et al. Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo. Circ Cardiovasc Imaging. 2009 ; 2 (6). 437-443
61. Cheng JF, Ni GH, Chen MF, et al. Involvement of profilin-1 in angiotensin II-induced vascular smooth muscle cell proliferation. Vascul Pharmacol. 2011 ; 55 (1-3). 34-41
62. Touyz RM. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Exp Physiol. 2005 ; 90 (4). 449-455
63. Hamming I, Timens W, Bulthuis ML, Lely AT, Navis GJ, van GH. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004 ; 203 (2). 631-637
64. Hayashi N, Yamamoto K, Ohishi M, et al. The counterregulating role of ACE2 and ACE2-mediated angiotensin 1-7 signaling against angiotensin II stimulation in vascular cells. Hypertens Res. 2010 ; 33 (11). 1182-1185
65. Jin XQ, Lu ZQ, Lin X. Effect of ACE2 gene transfection on the proliferation of vascular smooth muscle cells in rats. Zhonghua Yi Xue Za Zhi. 2011 ; 91 (2). 125-128
66. Igase M, Strawn WB, Gallagher PE, Geary RL, Ferrario CM. Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol. 2005 ; 289 (3). H1013 - H1019
67. Shi MM, Godleski JJ, Paulauskis JD. Regulation of macrophage inflammatory protein-1alpha mRNA by oxidative stress. J Biol Chem. 1996 ; 271 (10). 5878-5883